CAS 139952-87-7: N-(tert-butoxycarbonyl)-L-alanine-15N
Description:N-(tert-butoxycarbonyl)-L-alanine-15N is a derivative of the amino acid L-alanine, where the amino group is protected by a tert-butoxycarbonyl (Boc) group, and it contains a stable nitrogen isotope, 15N. This compound is characterized by its molecular structure, which includes a carbon backbone typical of amino acids, an amine functional group, and a carboxylic acid group, with the Boc group providing steric protection to the amine. The presence of the 15N isotope allows for specific applications in isotopic labeling studies, particularly in NMR spectroscopy and metabolic tracing in biological systems. The Boc protection is commonly used in peptide synthesis to prevent premature reactions of the amine group. This compound is typically utilized in research and development settings, particularly in the fields of biochemistry and medicinal chemistry, where it can serve as an intermediate in the synthesis of peptides or other bioactive molecules. Its stability and reactivity can be influenced by the conditions under which it is handled, making it important to consider storage and usage protocols.
Formula:C8H1515NO4
- Synonyms:
- Boc-[15N]Ala-OH
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | L-Alanine-15N, N-[(1,1-dimethylethoxy)carbonyl]- REF: IN-DA001BUVCAS: 139952-87-7 | - - - | To inquire | Tue 29 Apr 25 |
![]() | L-Alanine-15N-N-t-BOC REF: 3U-N3801CAS: | 99 atom % 15N | 478.00 € | Fri 02 May 25 |
![]() | L-Alanine-15N-N-t-BOC REF: TR-N600403CAS: 139952-87-7 | - - - | 94.00 € | Tue 10 Jun 25 |
![]() | Boc-[15N]Ala-OH REF: 3D-PFA95287CAS: 139952-87-7 | Min. 95% | - - - | Discontinued product |

L-Alanine-15N, N-[(1,1-dimethylethoxy)carbonyl]-
Ref: IN-DA001BUV
Undefined size | To inquire |

L-Alanine-15N-N-t-BOC
Ref: 3U-N3801
1g | 478.00 € |

L-Alanine-15N-N-t-BOC
Controlled ProductRef: TR-N600403
10mg | 94.00 € |

Boc-[15N]Ala-OH
Ref: 3D-PFA95287
1g | Discontinued | Request information | |
500mg | Discontinued | Request information |